WALTHAM, Massachusetts, Aug. 31 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its September 2024 edition (Vol. 3, No. 9):

* Adjunctive N-Acetylcysteine and Lung Function in Pulmonary Tuberculosis

* Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease

* Pregnancy after Tubal Sterili . . .

Click here for more information about our products